Epigenetics to study diseases such cancer, leukemia and multiple sclerosis


Biocat echoed the final meeting of the Consolider Epigenetics project, held on 12 and 13 May in Barcelona. Over the past 5 years that it has been running, this project has brought together the top European research groups in the field, including the IRB Barcelona Chromatin Structure and Function lab, led by Ferran Azorín. The project has come to an impressive end, with important findings in multiple sclerosis and cancer epigenetics and more than 150 scientific papers published in leading journals, like Cell Stem Cell, Nature Structural and Cancer Research.